Abstract
A lymphoma of African children, described as a distinct clinical entity by Burkitt in 1958 (1), has aroused considerable interest because epidemiological evidence strongly suggests that an external environmental factor is involved, possibly a vector- borne virus disease. Burkitt’s tumor occurs in high incidence in those regions of Africa where climatic conditions are favorable for the dissemination of arthropod- vectored agents (2, 3). A high incidence of the tumor, but not the geographic and climatic limitations noted in Africa, has also been observed in New Guinea (4). Cases in Africa are infrequent among adults residing in endemic areas. However, among immigrants from regions where the tumor is rare, nearly 50 percent were over 15 years of age. Racial and tribal characteristics have been said to be of no significance in susceptibility to tumor development. These observations suggest that immunity develops in most persons exposed to the inciting agent and may be a factor in the response of patients to therapy (5).
National Institutes of Health, Public Health Service, U.S. Department of Health, Education and Welfare.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Burkitt, D. P.: A sarcoma involving the jaws in African children. Brit. J. Surg. 46:218–223, 1958.
Burkitt, D. P. and Davies, J. N. P.: Lymphoma syndrome in Uganda and tropical Africa. Med. Press 245:567–369, 1961.
Haddow, A. J.: An improved map for the study of Burkitt’s lymphoma syndrome in Africa. E. Afr. Med. J. 40:429–432, 1963.
Ten Seldam, R. E. J., Cooke, R. A. and Anderson, L.: Childhood lymphoma in the territories of Papua and New Guinea. Cancer 19:437–446, 1966.
Burkitt, D. P. and Wright, D. H.: Geographical and tribal distribution of the African lymphoma in Uganda. Brit. Med. J. 1:569–573, 1966.
O’Conor, G. T., Rappaport, H. and Smith, E. B.: Childhood lymphoma resembling “Burkitt tumor” in the United States. Cancer 18:411–417, 1965.
Dorfman, R. R: Childhood lymphosarcoma in St. Louis, Missouri clinically and histologically resembling Burkitt’s tumor. Cancer 18:418–430, 1965.
Baskerville, A., Hunt, A. C. and Lucke, M. V.: Burkitt’s lymphoma in Great Britain. Lancet 2:547, 1966.
Lukes, R. J., Parker, J. W., Bell, R. E., McFride, N. L. and Madill, K. R.: Canine lymphomas histologically indistinguishable from Burkitt’s lymphoma. Lancet 2:389–390, 1966.
Squire, R. A.: Feline lymphoma. A comparison with the Burkitt tumor of children. Cancer 19:447–453, 1966.
Bell, T. M.: Viruses associated with Burkitt’s tumor. Prog. Med. Virol. 9:1–34, 1967.
Stanley, N. F., Walters, M. N. I., Leak, P. J. and Keast, D.: The association of a murine lymphoma with reovirus type 3 infection. Proc. Soc. Exp. Biol, Med. 121:90–94, 1966.
Bell, T. M., Munube, G. M. R. and Wright, D. H.: Malignant lymphoma in a rabbit inoculated with reovirus. Lancet 1:955–957, 1968.
Epstein, M. A., Achong, B. G. and Barr, Y. M.: Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1:702–703, 1964.
Henle, G. and Henle, W.: Immunofluorescence in cells derived from Burkitt’s lymphoma. J. Bact. 91:1248–1256, 1966.
Old, L. J., Boyse, E. A., Oettgen, H. F., deHarven, E., Geering, G., Williamson, B. and Clifford, P.: Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc. Nat. Acad. Sci. USA 56:1699–1704, 1966.
Moore, G. E., Gerner, R. E. and Franklin, H. A.: Culture of normal human leukocytes. J. Amer. Med. Ass. 199:519–524, 1967.
Moore, G. E., Ito, E., Ulrich, K., and Sandberg, A. A.: Culture of human leukemia cells. Cancer 19:713–723, 1966.
Henle, W., Diehl, V., Kohn, G. and Henle, G.: Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science 157: 1064–1065, 1967.
Landon, J. C., Ellis, L. B., Zeve, V. H. and Fabrizio, D. P. A.: Herpes-type virus in cultured leukocytes from chimpanzees. J. Nat. Cancer Inst. 40:181–192, 1968.
Armstrong, D., Henle, G. and Henle, W.: Complement-fixation tests with cell lines derived from Burkitt’s lymphoma and acute leukemia. J. Bact. 91:1257–1262, 1966.
Gerber, P. and Birch, S. M.: Complement-fixing antibodies in sera of human and non- human primates to viral antigens derived from Burkitt’s lymphoma cells. Proc. Natl. Acad. Sci. USA 58:478–484, 1967.
Henle, W., Henle, G. and Diehl, V.: Relation of Burkitt’s tumor-associated herpes- type virus to infectious mononucleosis. Proc. Nat. Acad. Sci. USA 59:94–101, 1968.
Horoszewicz, J. Unpublished results.
Benyesh-Melnick, M., Philips, C. F., Lewis, R. T. and Seidel, E. H.: Studies on acute leukemia and infectious mononucleosis of childhood. IV. Continuous propagation of lym- phoblastoid cells from spontaneously transformed bone marrow cultures. J. Nat. Cancer Inst. 40:123–134, 1968.
Benyesh-Melnick, M.: Personal communication.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1969 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Manaker, R.A. (1969). Viruses Associated with Burkitt’s Lymphoma. In: Mizell, M. (eds) Biology of Amphibian Tumors. Recent Results in Cancer Research, vol 1969. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85791-1_40
Download citation
DOI: https://doi.org/10.1007/978-3-642-85791-1_40
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-85793-5
Online ISBN: 978-3-642-85791-1
eBook Packages: Springer Book Archive